Top Markets
Coin of the day
Raphael Pharmaceutical Inc. Raphael Pharmaceutical Inc.

Raphael Pharmaceutical Inc.

RAPH
Pozycja w akcjach #28150
Raphael Pharmaceutical Inc. operates as a biopharmaceutical firm, concentrating... Raphael Pharmaceutical Inc. operates as a biopharmaceutical firm, concentrating its efforts on discovering and clinically developing novel therapeutic solutions. These treatments primarily leverage cannabinoids and are designed to enhance patients' quality of life. Currently, the company's leading investigational drug candidate is being advanced for the management of rheumatoid arthritis. Furthermore, Raphael Pharma plans to broaden its pipeline to include more cannabinoid-based medicines aimed at various cancer types and other autoimmune conditions. The company's corporate headquarters are situated in Tel Aviv-Jaffa, Israel.
Cena akcji
$1.40
Ostatnia synchronizacja: 2026-08-18
Kapitalizacja rynkowa
$28.25M
Zmiana (1 dzień)
0.00%
Zmiana (1 rok)
536.36%
Kraj
IL
Handel Raphael Pharmaceutical Inc. (RAPH)

Kategoria

Historia stopy dywidendy dla Raphael Pharmaceutical Inc. (RAPH)
Stopa dywidendy (TTM) dla Raphael Pharmaceutical Inc. (symbol akcji: RAPH) na dzień 2026 wynosi: 0
Średnia stopa dywidendy z ostatnich 5 lat: 0.00%
Historia stopy dywidendy dla Raphael Pharmaceutical Inc. (RAPH) od 2026 do 2026
Stopa dywidendy na koniec każdego roku (TTM)
Rok Stopa dywidendy Zmień
Za mało danych dla podanych dat.
Stopy dywidendy (TTM) dla podobnych firm lub konkurencji